As CBD Oils Become More Popular, The FDA Considers Whether To Set New Rules
The marijuana and hemp extract has been touted as a way to ease anxiety and inflammation, despite limited science. Now, the FDA is holding its first public hearing on cannabidiol.
by Allison Aubrey
May 31, 2019
3 minutes
The Food and Drug Administration is holding its first public hearing on CBD, the cannabis extract that has quickly grown into a billion-dollar industry. Today's hearing will help officials determine how to regulate CBD products.
The compound can be extracted from marijuana or from hemp. It's promoted as a way to ease anxiety and inflammation â and it doesn't get people high because it doesn't contain THC, the psychoactive component
You’re reading a preview, subscribe to read more.
Start your free 30 days